Baseline Characteristics and Preliminary Safety from a Multicenter, Safety Surveillance Study of Lecanemab Treatment for Alzheimer’s Disease in Real-World Clinical Practice using the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) Registry
